Light Sciences Oncology Secures $6,256,000 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1c7d2dca-52c4-4c4a-8ecf-d868a503c3dc&Preview=1 - Date
6/13/2011 - Company Name
Light Sciences Oncology - Mailing Address
15405 SE 37th Street Bellevue, WA 98006 - Company Description
Light Sciences Oncology is developing Light Infusion Therapy (Litx), an innovative light-activated treatment for solid tumors. LSO is currently developing Litx for the treatment of patients with cancers such as hepatoma, metastatic colorectal cancer and glioma, for which the current therapeutic alternatives are of limited efficacy. - Website
http://www.lsoncology.com - Transaction Type
Debt - Transaction Amount
$6,256,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
